# Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

> **NCT00641511** · PHASE2 · WITHDRAWN · sponsor: **Michael E. DeBakey VA Medical Center**

## Conditions studied

- Post Traumatic Stress Disorder (PTSD)

## Interventions

- **DRUG:** SYN117 (nepicastat)
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT00641511
- **Lead sponsor:** Michael E. DeBakey VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Houston site withdrew as a study site.
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641511, "Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00641511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*